X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2899) 2899
Publication (144) 144
Book Review (40) 40
Magazine Article (14) 14
Book Chapter (9) 9
Conference Proceeding (2) 2
Dissertation (1) 1
Newsletter (1) 1
Newspaper Article (1) 1
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2248) 2248
male (1493) 1493
female (1240) 1240
verapamil (1214) 1214
middle aged (1054) 1054
verapamil - therapeutic use (989) 989
verapamil - adverse effects (897) 897
adult (840) 840
aged (744) 744
animals (579) 579
index medicus (555) 555
verapamil - administration & dosage (513) 513
pharmacology & pharmacy (502) 502
verapamil - pharmacology (487) 487
hypertension - drug therapy (402) 402
calcium channel blockers - therapeutic use (397) 397
cardiac & cardiovascular systems (373) 373
blood pressure - drug effects (328) 328
calcium channel blockers - adverse effects (312) 312
electrocardiography (297) 297
drug therapy, combination (290) 290
treatment outcome (270) 270
drug interactions (254) 254
heart rate - drug effects (249) 249
rats (247) 247
double-blind method (240) 240
dose-response relationship, drug (221) 221
calcium channel blockers - pharmacology (202) 202
hypertension (202) 202
time factors (196) 196
nifedipine (193) 193
diltiazem (172) 172
adolescent (160) 160
drug therapy (159) 159
angina pectoris - drug therapy (156) 156
p-glycoprotein (155) 155
calcium channel blockers - administration & dosage (152) 152
medicine, general & internal (150) 150
hemodynamics - drug effects (148) 148
nifedipine - therapeutic use (146) 146
anti-arrhythmia agents - therapeutic use (136) 136
clinical trials as topic (135) 135
pharmacokinetics (135) 135
atrial fibrillation - drug therapy (131) 131
prospective studies (128) 128
therapy (128) 128
hypertension - physiopathology (125) 125
care and treatment (122) 122
diltiazem - therapeutic use (122) 122
calcium channel blockers (121) 121
drugs (121) 121
medicine & public health (119) 119
antihypertensive agents - therapeutic use (118) 118
risk factors (118) 118
toxicology (117) 117
delayed-action preparations (115) 115
administration, oral (114) 114
nifedipine - adverse effects (110) 110
aged, 80 and over (109) 109
calcium (108) 108
injections, intravenous (108) 108
blood pressure (106) 106
diltiazem - adverse effects (105) 105
peripheral vascular disease (105) 105
arrhythmias, cardiac - drug therapy (102) 102
anti-arrhythmia agents - adverse effects (101) 101
adrenergic beta-antagonists - therapeutic use (100) 100
analysis (100) 100
oncology (100) 100
health aspects (98) 98
vasodilator agents - therapeutic use (98) 98
clinical neurology (97) 97
surgery (96) 96
dogs (95) 95
double-blind (93) 93
research (90) 90
follow-up studies (89) 89
antihypertensive agents - adverse effects (87) 87
drug administration schedule (87) 87
pharmacology/toxicology (87) 87
child (84) 84
toxicity (84) 84
inhibition (83) 83
efficacy (82) 82
heart (82) 82
dosage and administration (81) 81
infusions, intravenous (81) 81
mice (81) 81
expression (80) 80
retrospective studies (80) 80
tachycardia, supraventricular - drug therapy (79) 79
urology & nephrology (79) 79
mortality (78) 78
hypotension - chemically induced (75) 75
tachycardia - drug therapy (75) 75
heart - drug effects (74) 74
cardiovascular system (72) 72
drug resistance (72) 72
multidrug-resistance (72) 72
vasodilator agents - administration & dosage (70) 70
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2625) 2625
German (100) 100
French (40) 40
Russian (35) 35
Spanish (28) 28
Italian (22) 22
Japanese (20) 20
Portuguese (15) 15
Polish (10) 10
Hebrew (8) 8
Danish (5) 5
Bulgarian (4) 4
Chinese (4) 4
Czech (4) 4
Norwegian (4) 4
Swedish (4) 4
Dutch (3) 3
Korean (3) 3
Croatian (2) 2
Finnish (2) 2
Hungarian (2) 2
Turkish (2) 2
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current Medical Research & Opinion, ISSN 0300-7995, 01/2013, Volume 29, Issue 1, pp. 1 - 12
Abstract Background: Rifampin is a potent inducer of both cytochrome P-450 oxidative enzymes and the P-glycoprotein transport system. Among numerous well... 
Rifabutin | Rifampin | Rifapentine | Drug interactions | MEDICINE, RESEARCH & EXPERIMENTAL | ENZYME-INDUCTION | PLATELET-AGGREGATION | ATORVASTATIN | SINGLE-BLIND | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | PHARMACOKINETICS | METABOLISM | PLASMA-CONCENTRATIONS | HEALTHY-VOLUNTEERS | TRANSPORTER INHIBITION | Rifampin - analogs & derivatives | Simvastatin - therapeutic use | Antifungal Agents - adverse effects | Digoxin - adverse effects | Simvastatin - adverse effects | Antibiotics, Antitubercular - adverse effects | Humans | ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism | Antifungal Agents - therapeutic use | Rifampin - adverse effects | Verapamil - therapeutic use | Drug Interactions | Verapamil - adverse effects | Rifampin - therapeutic use | Contraceptives, Oral - adverse effects | Contraceptives, Oral - therapeutic use | Digoxin - therapeutic use | HIV Protease Inhibitors - adverse effects | Rifabutin - adverse effects | Anti-Arrhythmia Agents - therapeutic use | HIV Protease Inhibitors - therapeutic use | Anticholesteremic Agents - adverse effects | Itraconazole - therapeutic use | Anticholesteremic Agents - therapeutic use | Anti-Arrhythmia Agents - adverse effects | Itraconazole - adverse effects | Antibiotics, Antitubercular - therapeutic use | Cytochrome P-450 Enzyme System - biosynthesis | Rifabutin - therapeutic use | ATP Binding Cassette Transporter, Sub-Family B | Index Medicus
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 11/2014, Volume 96, Issue 5, pp. 549 - 558
Journal Article
Circulation, ISSN 0009-7322, 04/2011, Volume 123, Issue 16, pp. 1721 - 1728
Journal Article
Acta Psychiatrica Scandinavica, ISSN 0001-690X, 07/2009, Volume 120, Issue 1, pp. 37 - 44
Objective:  Ecological studies have demonstrated a substantial decrease in suicide in parallel with an increase in the use of antidepressants. Causality... 
suicide prevention | forensic toxicology | selective serotonin reuptake inhibitor | antidepressants | suicide | pharmacoepidemiology | Pharmacoepidemiology | Forensic toxicology | Suicide | Suicide prevention | Antidepressants | Selective serotonin reuptake inhibitor | PRESCRIPTION DATABASE | DEPRESSION | WARNINGS | DRUG-USE | PSYCHIATRY | PREVENTION | RISK | CHILDREN | RATES | ADOLESCENTS | ASSOCIATION | Hypnotics and Sedatives - adverse effects | Vasodilator Agents - therapeutic use | Humans | Middle Aged | Suicide - prevention & control | Depressive Disorder - mortality | Depressive Disorder - drug therapy | Male | Risk | Hypnotics and Sedatives - therapeutic use | Tramadol - adverse effects | Drug Utilization Review | Case-Control Studies | Pyridines - adverse effects | Sweden | Verapamil - therapeutic use | Analgesics, Opioid - adverse effects | Verapamil - adverse effects | Azabicyclo Compounds - therapeutic use | Female | Drug Therapy, Combination | Azabicyclo Compounds - adverse effects | Pyridines - therapeutic use | Dextropropoxyphene - therapeutic use | Dextropropoxyphene - adverse effects | Analgesics, Opioid - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Suicide - trends | Antidepressive Agents - therapeutic use | Tramadol - therapeutic use | Cause of Death - trends | Antidepressive Agents - adverse effects | Vasodilator Agents - adverse effects | Neurosciences | Antidepressants, Tricyclic | Drug therapy | Causality | Suicides & suicide attempts | Index Medicus | suicide; suicide prevention; antidepressants; selective serotonin reuptake inhibitor; pharmacoepidemiology; forensic toxicology | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2004, Volume 351, Issue 11, pp. 1089 - 1096
Journal Article
Journal Article
Journal of Cardiovascular Pharmacology and Therapeutics, ISSN 1074-2484, 3/2019, Volume 24, Issue 2, pp. 193 - 203
Diabetes is a global epidemic disease, which leads to multiorgan dysfunction, including heart disease. Diabetes results from the limited absorption of glucose... 
AS160 | glucose transporter | skeletal muscle | diabetes | calcium channel blocker | heart | CARDIAC-FUNCTION | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | GLUCOSE-TRANSPORT | CALCIUM-CHANNEL BLOCKERS | HYDROCHLORIDE | SKELETAL-MUSCLE | INSULIN-STIMULATED PHOSPHORYLATION | CARDIOVASCULAR-DISEASE | RESISTANCE | PHARMACOLOGY & PHARMACY | VERAPAMIL
Journal Article
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2011, Volume 124, Issue 7, pp. 614 - 620
Abstract Background There is limited information about the safety of chronic nonsteroidal anti-inflammatory drugs (NSAIDs) in hypertensive patients with... 
Internal Medicine | Hypertension | Myocardial infarction | Nonsteroidal anti-inflammatory drugs | Coronary artery disease | NSAIDs | GASTROINTESTINAL TOXICITY | MYOCARDIAL-INFARCTION | CYCLOOXYGENASE | BLOOD-PRESSURE | TRIAL | MEDICINE, GENERAL & INTERNAL | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | CYCLO-OXYGENASE-2 INHIBITORS | NAPROXEN | OSTEOARTHRITIS | CARDIOVASCULAR RISK | Multivariate Analysis | Myocardial Infarction - chemically induced | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Follow-Up Studies | Humans | Middle Aged | Hypertension - drug therapy | Male | Verapamil - therapeutic use | Multicenter Studies as Topic | Stroke - chemically induced | Adult | Female | Stroke - epidemiology | Blood Pressure - drug effects | Stroke - mortality | Odds Ratio | Myocardial Infarction - etiology | Pyrazoles - adverse effects | Naproxen - adverse effects | Drug Administration Schedule | Diclofenac - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Celecoxib | Coronary Artery Disease - drug therapy | Antihypertensive Agents - therapeutic use | Randomized Controlled Trials as Topic | Stroke - etiology | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Confounding Factors (Epidemiology) | Coronary Artery Disease - complications | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Hypertension - complications | Sulfonamides - adverse effects | Indoles - therapeutic use | Aged | Ibuprofen - adverse effects
Journal Article
International Journal of Dermatology, ISSN 0011-9059, 10/2018, Volume 57, Issue 10, pp. 1192 - 1200
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 03/2014, Volume 275, Issue 2, pp. 163 - 175
Journal Article